CD8A and lymphoma: Based on these results, we conclude that the effector CD4+ T cells activated by LMP1/2A+ B lymphoma cells contain CD4+ CTLs that recognize and kill lymphoma cells in an MHC-II-specific manner, while CD8+ CTLs kill target cells dependent on MHC-I as expected.